Tabimorelin is an orally active, synthetic growth hormone secretagogue that functions as an agonist at the ghrelin receptor to stimulate growth hormone release. While investigated for potential applications… Read more
Tabimorelin is an orally active, synthetic growth hormone secretagogue that functions as an agonist at the ghrelin receptor to stimulate growth hormone release. While investigated for potential applications in addressing growth hormone deficiency, it remains an experimental compound. The Tabimorelin category provides essential reference standards, including the active pharmaceutical ingredient (API), related pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. These materials are critical tools for analytical laboratories, supporting rigorous impurity profiling, method validation, and quality control. By serving as reliable benchmarks, these standards allow for precise qualitative and quantitative analysis, enabling researchers and analytical chemists to verify identity, purity, and concentration during development and research. These compounds ensure reproducibility and data integrity in experiments involving this ghrelin receptor agonist, facilitating accurate identification of degradation products and metabolites within complex biological or chemical matrices.